Suppr超能文献

CXCL8 及其在黑色素瘤进展和转移中的同源受体。

CXCL8 and its cognate receptors in melanoma progression and metastasis.

机构信息

Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, AL, USA.

出版信息

Future Oncol. 2010 Jan;6(1):111-6. doi: 10.2217/fon.09.128.

Abstract

The incidence of melanoma is rising at an alarming rate and we are still awaiting an effective treatment for this malignancy. In its early stage, melanoma can be cured by surgical removal, but once metastasis has occurred there is no effective treatment. Recent findings have suggested multiple functional implications of CXCL8 and its cognate receptors, CXCR1 and CXCR2, in melanoma pathogenesis, thus underscoring their importance as targets for cancer therapy. This review provides an update on the roles of CXCL8 and its receptors in melanoma progression and metastasis.

摘要

黑色素瘤的发病率正在以惊人的速度上升,而我们仍在等待这种恶性肿瘤的有效治疗方法。在早期阶段,黑色素瘤可以通过手术切除来治愈,但一旦发生转移,就没有有效的治疗方法。最近的研究结果表明,CXCL8 及其同源受体 CXCR1 和 CXCR2 在黑色素瘤发病机制中具有多种功能意义,因此强调了它们作为癌症治疗靶点的重要性。本文综述了 CXCL8 及其受体在黑色素瘤进展和转移中的作用。

相似文献

3
The CXCL8-CXCR1/2 pathways in cancer.癌症中的CXCL8-CXCR1/2信号通路。
Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25.
6

引用本文的文献

本文引用的文献

2
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
6
The good and the bad of chemokines/chemokine receptors in melanoma.趋化因子/趋化因子受体在黑色素瘤中的利弊
Pigment Cell Melanoma Res. 2009 Apr;22(2):175-86. doi: 10.1111/j.1755-148X.2009.00554.x. Epub 2009 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验